What to Expect From Eastman Chemical's Q3 2025 Earnings Report

Core Viewpoint - Eastman Chemical Company (EMN) is facing significant challenges with declining earnings expectations and a substantial drop in share price over the past year, while analysts maintain a cautiously optimistic outlook on the stock's potential recovery [2][4][6]. Financial Performance - EMN is expected to report an adjusted EPS of $1.21 for fiscal Q3 2025, reflecting a 46.5% decline from $2.26 in the same quarter last year [2]. - For fiscal 2025, analysts forecast an adjusted EPS of $5.91, a decrease of 25.1% from $7.89 in fiscal 2024, but anticipate a recovery with a projected adjusted EPS of $6.97 in fiscal 2026, representing a year-over-year growth of 17.9% [3]. Stock Performance - Over the past 52 weeks, EMN shares have decreased by 45.7%, underperforming the S&P 500 Index, which gained 14.4%, and the Materials Select Sector SPDR Fund, which saw a nearly 8% decrease [4]. - Following the Q2 2025 results announcement, EMN shares fell over 19% after reporting an adjusted EPS of $1.60, which missed Wall Street's expectations, despite revenue of $2.29 billion meeting forecasts [5]. Analyst Sentiment - The consensus among analysts is a "Moderate Buy" rating for EMN, with eight out of 15 analysts recommending a "Strong Buy," two a "Moderate Buy," four a "Hold," and one a "Strong Sell" [6]. - The average analyst price target for Eastman Chemical is $74.40, indicating a potential upside of 23.9% from current levels [6].